文献速递白血病

NT5C2胚系变异改变硫嘌呤代谢并与儿童急性淋巴细胞白血病获得性NT5C2复发突变相关

NT5C2 germline variants alter thiopurine metabolism and are associated with acquired NT5C2 relapse mutations in childhood acute lymphoblastic leukaemia.
PubMed 文献 · Leukemia · 2018-09-10

研究在1009例接受维持治疗的急性淋巴细胞白血病(ALL)患儿中分析红细胞硫鸟嘌呤核苷酸(Ery-TGN)和DNA-TG的时间加权均值,发现NT5C2内含子SNP rs72846714与DNA-TG掺入倾向显著相关,验证队列中该关联在维持治疗早期和晚期均显著;rs72846714与复发风险无关,但在180例复发ALL患儿中与复发特异性NT5C2功能获得性突变增加相关(P=0.03)。

要点

  • rs72846714与DNA-TG掺入倾向相关,顶位P=2.09×10-10,次要等位基因频率15%。
  • 校正Ery-TGN后,rs72846714-A基因型仍与较高DNA-TG相关(P=0.029)。
  • rs72846714与复发风险无关,但与复发特异性NT5C2功能获得性突变增加相关(P=0.03)。

核心结论

  • NT5C2胚系变异影响硫嘌呤代谢,且与儿童ALL复发时获得性NT5C2功能获得性突变相关。

研究设计与样本

  • 全基因组关联研究,纳入1009例接受维持治疗的急性淋巴细胞白血病(ALL)患者,分析红细胞TGN和DNA-TG的时间加权均值。
  • 发现分析454例,验证分析555例。
  • 另在180例复发ALL患儿队列中分析rs72846714与复发特异性NT5C2突变的关系。

主要发现

  • 发现分析中,DNA-TG掺入倾向(wmDNA-TG/wmEry-TGN比值)与NT5C2三个内含子SNP显著相关,顶位为rs72846714(P=2.09×10-10,次要等位基因频率15%)。
  • 验证分析中,该关联在维持治疗早期和晚期均保持显著(P=8.4×10-6和1.3×10-3)。
  • 校正wmEry-TGN后(P<0.0001),rs72846714-A基因型仍与较高wmDNA-TG相关(P=0.029)。
  • 靶向测序NT5C2未发现与rs72846714或wmEry-TGN/wmDNA-TG相关的错义变异。
  • rs72846714与复发风险无关,但在180例复发ALL患儿中,rs72846714-A基因型与复发特异性NT5C2功能获得性突变(降低胞质TGN水平)发生增加相关(P=0.03)。

关键数值与推荐

  • DNA-TG掺入倾向与rs72846714关联的顶位P=2.09×10-10,次要等位基因频率15%。
  • 验证分析中该关联在维持治疗早期P=8.4×10-6,晚期P=1.3×10-3。
  • 校正wmEry-TGN后(P<0.0001),rs72846714-A与较高wmDNA-TG相关(P=0.029)。
  • 复发ALL患儿中rs72846714-A与复发特异性NT5C2功能获得性突变增加相关(P=0.03)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The antileukaemic drug 6-mercaptopurine is converted into thioguanine nucleotides (TGN) and incorporated into DNA (DNA-TG), the active end metabolite. In a series of genome-wide association studies, we analysed time-weighted means (wm) of erythrocyte concentrations of TGN (Ery-TGN) and DNA-TG in 1009 patients undergoing maintenance therapy for acute lymphoblastic leukaemia (ALL). In discovery analyses (454 patients), the propensity for DNA-TG incorporation (wmDNA-TG/wmEry-TGN ratio) was significantly associated with three intronic SNPs in NT5C2 (top hit: rs72846714; P = 2.09 × 10-10, minor allele frequency 15%). In validation analyses (555 patients), this association remained significant during both early and late maintenance therapy (P = 8.4 × 10-6 and 1.3 × 10-3, respectively). The association was mostly driven by differences in wmEry-TGN, but in regression analyses adjusted for wmEry-TGN (P < 0.0001), rs72846714-A genotype was also associated with a higher wmDNA-TG (P = 0.029). Targeted sequencing of NT5C2 did not identify any missense variants associated with rs72846714 or wmEry-TGN/wmDNA-TG. rs72846714 was not associated with relapse risk, but in a separate cohort of 180 children with relapsed ALL, rs72846714-A genotype was associated with increased occurrence of relapse-specific NT5C2 gain-of-function mutations that reduce cytosol TGN levels (P = 0.03). These observations highlight the impact of both germline and acquired mutations in drug metabolism and disease trajectory.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Tulstrup M, Grosjean M, Nielsen SN, et al. NT5C2 germline variants alter thiopurine metabolism and are associated with acquired NT5C2 relapse mutations in childhood acute lymphoblastic leukaemia. Leukemia. 2018. PMID: 30201983. doi:10.1038/s41375-018-0245-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。